These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12509418)

  • 1. Topoisomerase III can serve as the cellular decatenase in Escherichia coli.
    Nurse P; Levine C; Hassing H; Marians KJ
    J Biol Chem; 2003 Mar; 278(10):8653-60. PubMed ID: 12509418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for topoisomerase III in Escherichia coli chromosome segregation.
    Perez-Cheeks BA; Lee C; Hayama R; Marians KJ
    Mol Microbiol; 2012 Nov; 86(4):1007-22. PubMed ID: 23066834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escherichia coli topoisomerase IV. Purification, characterization, subunit structure, and subunit interactions.
    Peng H; Marians KJ
    J Biol Chem; 1993 Nov; 268(32):24481-90. PubMed ID: 8227000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase III Acts at the Replication Fork To Remove Precatenanes.
    Lee CM; Wang G; Pertsinidis A; Marians KJ
    J Bacteriol; 2019 Apr; 201(7):. PubMed ID: 30617245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between type 1A topoisomerases and gyrase in chromosome segregation in Escherichia coli.
    Usongo V; Tanguay C; Nolent F; Bessong JE; Drolet M
    J Bacteriol; 2013 Apr; 195(8):1758-68. PubMed ID: 23396913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of dnaX as a high-copy suppressor of the conditional lethal and partition phenotypes of the parE10 allele.
    Levine C; Marians KJ
    J Bacteriol; 1998 Mar; 180(5):1232-40. PubMed ID: 9495763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decatenating activity of Escherichia coli DNA gyrase and topoisomerases I and III during oriC and pBR322 DNA replication in vitro.
    Hiasa H; DiGate RJ; Marians KJ
    J Biol Chem; 1994 Jan; 269(3):2093-9. PubMed ID: 8294462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A ParE-ParC fusion protein is a functional topoisomerase.
    Lavasani LS; Hiasa H
    Biochemistry; 2001 Jul; 40(29):8438-43. PubMed ID: 11456480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topoisomerase III, but not topoisomerase I, can support nascent chain elongation during theta-type DNA replication.
    Hiasa H; Marians KJ
    J Biol Chem; 1994 Dec; 269(51):32655-9. PubMed ID: 7798272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-molecule analysis uncovers the difference between the kinetics of DNA decatenation by bacterial topoisomerases I and III.
    Terekhova K; Marko JF; Mondragón A
    Nucleic Acids Res; 2014 Oct; 42(18):11657-67. PubMed ID: 25232096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decatenation activity of topoisomerase IV during oriC and pBR322 DNA replication in vitro.
    Peng H; Marians KJ
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8571-5. PubMed ID: 8104339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting enzymatic activities of topoisomerase IV and DNA gyrase from Escherichia coli.
    Ullsperger C; Cozzarelli NR
    J Biol Chem; 1996 Dec; 271(49):31549-55. PubMed ID: 8940171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topoisomerases I and III inhibit R-loop formation to prevent unregulated replication in the chromosomal Ter region of Escherichia coli.
    Brochu J; Vlachos-Breton É; Sutherland S; Martel M; Drolet M
    PLoS Genet; 2018 Sep; 14(9):e1007668. PubMed ID: 30222737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of DNA decatenation by Escherichia coli topoisomerase IV and topoisomerase III: implications for non-equilibrium topology simplification.
    Seol Y; Hardin AH; Strub MP; Charvin G; Neuman KC
    Nucleic Acids Res; 2013 Apr; 41(8):4640-9. PubMed ID: 23460205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases.
    Blanche F; Cameron B; Bernard FX; Maton L; Manse B; Ferrero L; Ratet N; Lecoq C; Goniot A; Bisch D; Crouzet J
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2714-20. PubMed ID: 9124828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a potent decatenating enzyme from Escherichia coli.
    DiGate RJ; Marians KJ
    J Biol Chem; 1988 Sep; 263(26):13366-73. PubMed ID: 2843517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoroquinolones inhibit preferentially Streptococcus pneumoniae DNA topoisomerase IV than DNA gyrase native proteins.
    Fernandez-Moreira E; Balas D; Gonzalez I; de la Campa AG
    Microb Drug Resist; 2000; 6(4):259-67. PubMed ID: 11272253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance.
    Pan XS; Fisher LM
    J Bacteriol; 1996 Jul; 178(14):4060-9. PubMed ID: 8763932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a unique domain essential for Escherichia coli DNA topoisomerase III-catalysed decatenation of replication intermediates.
    Li Z; Mondragón A; Hiasa H; Marians KJ; DiGate RJ
    Mol Microbiol; 2000 Feb; 35(4):888-95. PubMed ID: 10692165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones.
    Ferrero L; Cameron B; Manse B; Lagneaux D; Crouzet J; Famechon A; Blanche F
    Mol Microbiol; 1994 Aug; 13(4):641-53. PubMed ID: 7997176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.